TWIST BIOSCIENCE CORP (1TWST.MI) Stock Fundamental Analysis

BIT:1TWST • US90184D1000

33.84 EUR
+4.35 (+14.75%)
Last: Jan 14, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

1TWST gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 78 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for 1TWST as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, 1TWST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year 1TWST has reported negative net income.
  • In the past year 1TWST has reported a negative cash flow from operations.
  • 1TWST had negative earnings in each of the past 5 years.
  • In the past 5 years 1TWST always reported negative operating cash flow.
1TWST.MI Yearly Net Income VS EBIT VS OCF VS FCF1TWST.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -12.10%, 1TWST is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -16.42%, 1TWST is in the better half of the industry, outperforming 69.32% of the companies in the same industry.
Industry RankSector Rank
ROA -12.1%
ROE -16.42%
ROIC N/A
ROA(3y)-24.14%
ROA(5y)-23.35%
ROE(3y)-31.13%
ROE(5y)-29.44%
ROIC(3y)N/A
ROIC(5y)N/A
1TWST.MI Yearly ROA, ROE, ROIC1TWST.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • 1TWST has a Gross Margin of 50.72%. This is comparable to the rest of the industry: 1TWST outperforms 48.86% of its industry peers.
  • 1TWST's Gross Margin has improved in the last couple of years.
  • 1TWST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.04%
GM growth 5Y9.75%
1TWST.MI Yearly Profit, Operating, Gross Margins1TWST.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • 1TWST does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1TWST has more shares outstanding
  • Compared to 5 years ago, 1TWST has more shares outstanding
  • 1TWST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1TWST.MI Yearly Shares Outstanding1TWST.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
1TWST.MI Yearly Total Debt VS Total Assets1TWST.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 6.09 indicates that 1TWST is not in any danger for bankruptcy at the moment.
  • 1TWST's Altman-Z score of 6.09 is fine compared to the rest of the industry. 1TWST outperforms 78.41% of its industry peers.
  • There is no outstanding debt for 1TWST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.09
ROIC/WACCN/A
WACC8.88%
1TWST.MI Yearly LT Debt VS Equity VS FCF1TWST.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.64 indicates that 1TWST has no problem at all paying its short term obligations.
  • The Current ratio of 1TWST (3.64) is better than 69.32% of its industry peers.
  • A Quick Ratio of 3.33 indicates that 1TWST has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.33, 1TWST is in the better half of the industry, outperforming 69.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.33
1TWST.MI Yearly Current Assets VS Current Liabilites1TWST.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • 1TWST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.39%, which is quite impressive.
  • 1TWST shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.32%.
  • Measured over the past years, 1TWST shows a very strong growth in Revenue. The Revenue has been growing by 33.11% on average per year.
EPS 1Y (TTM)41.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.73%
Revenue 1Y (TTM)20.32%
Revenue growth 3Y22.75%
Revenue growth 5Y33.11%
Sales Q2Q%16.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.82% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 15.84% on average over the next years. This is quite good.
EPS Next Y23.93%
EPS Next 2Y20.28%
EPS Next 3Y18.82%
EPS Next 5YN/A
Revenue Next Year15.05%
Revenue Next 2Y15.06%
Revenue Next 3Y15.45%
Revenue Next 5Y15.84%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1TWST.MI Yearly Revenue VS Estimates1TWST.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
1TWST.MI Yearly EPS VS Estimates1TWST.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • 1TWST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year 1TWST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1TWST.MI Price Earnings VS Forward Price Earnings1TWST.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1TWST.MI Per share data1TWST.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1TWST's earnings are expected to grow with 18.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.28%
EPS Next 3Y18.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1TWST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TWIST BIOSCIENCE CORP

BIT:1TWST (1/14/2026, 7:00:00 PM)

33.84

+4.35 (+14.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)02-02
Inst Owners119.83%
Inst Owner ChangeN/A
Ins Owners2.08%
Ins Owner ChangeN/A
Market Cap2.07B
Revenue(TTM)376.57M
Net Income(TTM)-77.67M
Analysts84.71
Price Target34.8 (2.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.37%
Min EPS beat(2)-2.79%
Max EPS beat(2)17.53%
EPS beat(4)2
Avg EPS beat(4)5.13%
Min EPS beat(4)-12.39%
Max EPS beat(4)18.15%
EPS beat(8)5
Avg EPS beat(8)-4.84%
EPS beat(12)9
Avg EPS beat(12)4.41%
EPS beat(16)13
Avg EPS beat(16)8.12%
Revenue beat(2)0
Avg Revenue beat(2)-0.88%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)0%
Revenue beat(8)5
Avg Revenue beat(8)1.19%
Revenue beat(12)8
Avg Revenue beat(12)1.55%
Revenue beat(16)11
Avg Revenue beat(16)2.24%
PT rev (1m)-6.56%
PT rev (3m)N/A
EPS NQ rev (1m)-4.09%
EPS NQ rev (3m)-1.43%
EPS NY rev (1m)-3.81%
EPS NY rev (3m)-7.78%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.45
P/FCF N/A
P/OCF N/A
P/B 5.14
P/tB 6.44
EV/EBITDA N/A
EPS(TTM)-1.8
EYN/A
EPS(NY)-1.37
Fwd EYN/A
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS5.24
BVpS6.59
TBVpS5.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.1%
ROE -16.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.72%
FCFM N/A
ROA(3y)-24.14%
ROA(5y)-23.35%
ROE(3y)-31.13%
ROE(5y)-29.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.04%
GM growth 5Y9.75%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 112.68%
Cap/Sales 7.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.33
Altman-Z 6.09
F-Score5
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)74.54%
Cap/Depr(5y)223.62%
Cap/Sales(3y)6.8%
Cap/Sales(5y)18.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.73%
EPS Next Y23.93%
EPS Next 2Y20.28%
EPS Next 3Y18.82%
EPS Next 5YN/A
Revenue 1Y (TTM)20.32%
Revenue growth 3Y22.75%
Revenue growth 5Y33.11%
Sales Q2Q%16.88%
Revenue Next Year15.05%
Revenue Next 2Y15.06%
Revenue Next 3Y15.45%
Revenue Next 5Y15.84%
EBIT growth 1Y22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.49%
EBIT Next 3Y26.49%
EBIT Next 5Y27.35%
FCF growth 1Y-9.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.69%
OCF growth 3YN/A
OCF growth 5YN/A

TWIST BIOSCIENCE CORP / 1TWST.MI FAQ

Can you provide the ChartMill fundamental rating for TWIST BIOSCIENCE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to 1TWST.MI.


What is the valuation status for 1TWST stock?

ChartMill assigns a valuation rating of 0 / 10 to TWIST BIOSCIENCE CORP (1TWST.MI). This can be considered as Overvalued.


Can you provide the profitability details for TWIST BIOSCIENCE CORP?

TWIST BIOSCIENCE CORP (1TWST.MI) has a profitability rating of 2 / 10.


How financially healthy is TWIST BIOSCIENCE CORP?

The financial health rating of TWIST BIOSCIENCE CORP (1TWST.MI) is 8 / 10.